Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

NCT00357656 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Recombinant Protein-Free Factor VIII (rAHF-PFM)
DRUG: Recombinant Protein-Free Factor VIII (rAHF-PFM)

Sponsor

Baxalta now part of Shire

Collaborators

[object Object]